Cipla Pharma Appoints Dr Reddy’s Former Us Generics Head As Global CFO

Umang Vohra as Cipla’s Global Chief Financial and Strategy Officer would bring deep insights about the global generics industry and understanding of value creation.

Indian pharmaceutical and biotechnology company, Cipla Limited appointed former head of Dr Reddy's North American business Umang Vohra as its Global Chief Financial and Strategy Officer.

While, former HR Head of Reliance Industries Prabir Jha is appointed as Global Chief People Officer.

Cipla Urges Government to Support Capital Investment, Encourage Research & Development
The government should bring in attractive market conditions by supporting capital investment, encourage R&D and create a favourable tax environment, said Cipla chairman.

These changes will be effective from October 1, the company said in a BSE filing.

Further the company said that Jha, in addition to providing leadership to the human resources function globally will lead the corporate communications and administration functions as well.

Commenting about the appointment of Vohra, Cipla Ltd MD and Global CEO Subhanu Saxena said, "He brings deep insights about the global generics industry as well as an understanding of value creation through his background in leading business and finance roles."

New Low-Cost Drug Manufactured by Cipla Launched in Uganda for HIV Treatment
The single-dose Trioday treatment, which costs $13 per month, replaces the cumbersome 12-drug cocktails which was the only option for people with HIV.

Prior to Dr Reddy's, Vohra worked with PepsiCo and Eicher Motors.

Samina Vaziralli, Executive Director who has been interim Head of HR said, "We truly believe focusing and building on human capital is one of the ultimate sources of sustainable, competitive advantage."

Cipla Soon to Launch Generic Hepatitis C Drug as Hepcvir
Cipla has signed a licensing agreement with Gilead to manufacture the drug Sofosbuvir and it will be made available as Hepcvir in India.

Source-PTI

Cipla and Strides Sign Pact With MMV: Fight Against Malaria
In collaboration with MMV, based in Switzerland, Cipla and Strides Arcolab venture to develop rectal artesunate for pre-referral malaria treatment severe in children.